T.H. Hall, H. Adams, V.K. Vyas et al.
Tetrahedron xxx (xxxx) xxx
88.4, 85.3, 62.4, 55.3, 39.4, 31.5; HRMS (ESI) m/z: [MþNa]þ calcd for
was prepared using General Procedure 3 from compound 35
(0.2407 g, 0.896 mmol, 1.00 eq.) and MnO2 (0.5390 g, 6.27 mmol,
7.00 eq.) to yield the desired product as a yellow solid (0.2146 g,
0.806 mmol, 90%).dH (400 MHz, CDCl3) 7.88 (1H, d, J ¼ 16.0 Hz,
COCH]CH), 7.68e7.56 (4H, m, ArH), 7.49e7.30 (5H, m, ArH), 6.86
(1H, d, J ¼ 16.2 Hz, COCH]CH); dC (101 MHz, CDCl3) 177.9, 148.5,
C
18H18NaO2 289.1196 found 289.1199; IR (v): 3346, 2911, 2216,1890,
1605, 1569, 1507, 1302, 1244, 1032, 825, 751, 697 cmꢁ1; Chiral HPLC
(CHIRALPAK IB column: (0.46 ꢂ 25 cm), 1.0 mL/min, IPA:Hexane
(10:90); 250 nm UV, 30 ꢀC): retention times: 10.47 (R)-unsaturated
and 15.20 (S)-unsaturated mins. Data matched that reported.
137.0, 134.2, 134.0, 131.3, 129.2, 129.1, 128.8, 128.4, 118.7, 90.1, 87.4;
35
4.1.41. rac-(E)-5-(4-Methoxyphenyl)-1-phenylpent-1-en-4-yn-3-ol
33
HRMS (ESI) m/z: [MþNa]þ calcd for C17
H ClNaO 289.0391, found
11
289.0392; IR (v): 3029, 2894, 2883, 2210, 1672, 1627, 1485, 1447,
1342, 1176, 1085, 970, 862, 815, 690, 582 cmꢁ1; Mp 145.9 ꢀC; Chiral
HPLC (CHIRALPAK ADH column: (0.46 ꢂ 25 cm), 0.7 mL/min,
IPA:Hexane (10:90); 250 nm UV, 30 ꢀC): retention time: 15.48
(ketone) mins. Data matched that reported.
This compound is known and has been partially characterised
[51]. Compound 33 was prepared using General Procedure 2. 1-
Ethynyl-4-methoxybenzene (0.5497 g, 4.16 mmol, 1.10 eq.) was
dissolved in THF (anhyd. 7.0 mL) and n-butyllithium (1.6 M in
hexanes, 2.60 mL, 4.16 mmol, 1.10 eq.) was added dropwise. After
30 min E-cinnamaldehyde (0.500 g, 3.78 mmol, 1.00 eq.) was
added. The crude was purified using column chromatography
(SiO2; Rf: 0.50 (4:1) petroleum/EtOAc) to give the desired product
33 as a yellow oil (0.7203 g, 2.72 mmol, 72%). dH (400 MHz, CDCl3)
7.46e7.31 (4H, m, ArH), 7.31e7.26 (3H, m, ArH), 6.89e6.77 (3H, m,
ArH and CH¼CHPh), 6.38 (1H, dd, J ¼ 15.8, 6.0 Hz, CH¼CHPh), 5.27
(1H, d, J ¼ 5.2 Hz, CHOH), 3.74 (3H, s, OMe), 2.08 (1H, s, OH); dC
(101 MHz, CDCl3) 159.9, 138.1, 136.2, 133.3, 131.9, 128.6, 128.3, 128.1,
126.8, 114.0, 86.6, 86.5, 63.6, 55.3; HRMS (ESI) m/z: [MþNa]þ calcd
for C18H16NaO2 287.1040, found 287.1044; IR (v): 3327, 2835, 2209,
4.1.45. rac-1-(4-Chlorophenyl)-5-phenylpent-1-yn-3-ol 34
This compound is novel. Compound 34 was prepared using
General Procedure 2. 1-Chloro-4-ethynylbenzene (0.407 g,
2.98 mmol, 1.00 eq.) was dissolved in THF (anhyd. 5.00 mL) and n-
butyllithium (2.5 M in hexanes, 1.19 mL, 2.98 mmol, 1.00 eq.) was
added dropwise. 3-phenylpropanal (0.400 g, 2.98 mmol, 1.00 eq.)
was added after 30 min. The crude was purified using column
chromatography (SiO2; Rf:0.3 (9:1) petroleum/EtOAc) to give the
desired product 34 as an orange solid (0.386 g, 1.43 mmol, 48%). dH
(400 MHz, CDCl3) 7.37e7.19 (9H, m, ArH), 4.59 (1H, q, J ¼ 6.1 Hz,
CHOH), 2.86 (2H, t, J ¼ 7.8 Hz, CH2CH2Ph), 2.18e2.07 (2H, m,
CH2CH2Ph), 1.87 (1H, d, J ¼ 5.4 Hz, OH); dC (101 MHz, CDCl3) 141.2,
1603, 1507, 1290, 1246, 1173, 1029, 967, 833, 750, 693, 534 cmꢁ1
;
Chiral HPLC (CHIRALPAK IB column: (0.46 ꢂ 25 cm), 1.0 mL/min,
IPA:Hexane (10:90); 250 nm UV, 30 ꢀC): retention times: 11.28 (R)-
unsaturated and 20.72 (S)-unsaturated mins. Data matched that
reported.
138.2, 136.6, 134.6, 132.9, 128.7, 128.5, 128.5, 126.1, 121.0, 90.8, 84.2,
35
62.2, 39.2, 31.5; HRMS (ESI) m/z: [MþNa]þ calcd for C17
H ClNaO
15
293.0704, found 293.0707; IR (v): 3209, 3060, 3025, 2952, 2919,
2858, 2229,1902, 1801, 1719, 1648, 1487,1453, 1395, 1087, 1012, 826,
756, 699, 522 cmꢁ1; Mp: 48.5e50.7 ꢀC; Chiral HPLC (CHIRALPAK
ADH column: (0.46 ꢂ 25 cm), 0.7 mL/min, IPA:Hexane (10:90);
250 nm UV, 30 ꢀC): retention times: 14.52 (R)-saturated and 15.54
(S)-saturated mins.
4.1.42. 1-(4-Methoxyphenyl)-5-phenylpent-1-yn-3-one
This compound is novel. This compound was prepared using
General Procedure 3 from compound 32 (0.3122 g, 1.17 mmol, 1.00
eq.) and MnO2 (0.714 g, 8.22 mmol, 7.00 eq.) to yield the desired
product as a yellow solid (0.1521 g, 0.57 mmol, 49%). dH (400 MHz,
CDCl3) 7.54e7.48 (2H, m, ArH), 7.33e7.17 (5H, m, ArH), 6.91e6.87
(2H, m, ArH), 3.84 (3H, s, OMe), 3.10e3.04 (2H, m, CH2CH2Ph),
3.08e2.95 (2H, m, CH2CH2Ph). dC (101 MHz, CDCl3) 186.9, 161.7,
140.4, 135.2, 128.6, 128.4, 126.3, 114.4, 111.7, 92.4, 87.7, 55.4, 46.9,
30.1; HRMS (ESI) m/z: [MþNa]þ calcd for C18H16NaO2 287.12 found
287.20; Chiral HPLC (CHIRALPAK IB column: (0.46 ꢂ 25 cm), 1.0 mL/
min, IPA:Hexane (10:90); 250 nm UV, 30 ꢀC): retention times: 6.81
(ketone) mins.
4.1.46. rac-(E)-5-(4-Chlorophenyl)-1-phenylpent-1-en-4-yn-3-ol
35
This compound is novel. Compound 35 was prepared using
General Procedure 2. 1-Chloro-4-ethynylbenzene (0.73 g,
5.67 mmol, 1.00 eq.) was dissolved in THF (anhyd. 8 mL) and n-
butyllithium (2.5 M in hexanes, 2.27 mL, 5.67 mmol, 1.00 eq.) was
added dropwise. After 30 min, E-cinnamaldehyde (0.75 g,
5.67 mmol, 1 eq.) was added. The crude product was purified using
column chromatography (SiO2; Rf: 15:1 (9:1) petroleum/EtOAc) to
give the desired product 35 as a yellow oil (0.2327 g, 0.85 mmol,
15%). dH (400 MHz, CDCl3) 7.40e7.19 (9H, m, ArH), 6.75 (1H, dd,
J ¼ 15.8,1.4 Hz, CH¼CHPh), 6.30 (1H, dd, J ¼ 15.8, 6.1 Hz, CH¼CHPh),
5.20 (1H, d, J ¼ 5.9 Hz, CHOH), 2.07 (1H, s, OH); dC (101 MHz, CDCl3)
4.1.43. (R)-1-(4-Methoxyphenyl)-5-phenylpent-1-yn-3-ol 32 and
(R,E)-5-(4-methoxyphenyl)-1-phenylpent-1-en-4-yn-3-ol 33
The ATH was conducted using General Procedure 1. (E)-5-(4-
Methoxyphenyl)-1-phenylpent-1-en-4-yn-3-one
(150
mg,
0.57 mmol,1.00 eq.), (R,R)-2 (3.6 mg, 5.72 mol, 0.01 eq.) and MeOH
m
136.0, 134.7, 133.0,132.2, 128.7, 128.7, 128.3, 127.8, 126.9, 120.9, 88.9,
85.3, 63.5; HRMS (ESI) m/z: [MþNa]þ calcd for C17
H ClNaO
13
35
(0.5 mL) was reacted for 26 h at 40 ꢀC. The crude product was
purified using column chromatography (SiO2; Rf: 0.10 (9:1) petro-
leum/EtOAc) to give a mixture of both alcohol products 32 and 33
(0.1375 g, 0.51 mmol, 90%). The product obtained was a pale-yellow
oil with an NMR ratio of 86:14 of the major 32 and minor 33
product. Enantiomeric excess and conversion were determined by
Chiral HPLC analysis (CHIRALPAK IB column: (0.46 ꢂ 25 cm),1.0 mL/
min, IPA:Hexane (10:90); 250 nm UV, 30 ꢀC): retention times: 9.52
(R)-saturated, 11.40 (R)-unsaturated, 12.66 (S)-saturated and 21.04
(S)-unsaturated mins. Conversion was determined to be 98% and
the ee of the major and minor product was determined to be 95%
(32) and 78% (33) respectively.
291.0546, found 293.0547; IR (v): 3298, 3028, 2852, 2661, 2228,
1648, 1475, 1447, 1398, 1248, 1202, 1090, 1060, 1020, 967, 828,
760 cmꢁ1; Chiral HPLC (CHIRALPAK ADH column: (0.46 ꢂ 25 cm),
0.7 mL/min, IPA:Hexane (10:90); 250 nm UV, 30 ꢀC): retention
times: 23.68 (R)-unsaturated and 27.11 (S)-unsaturated mins.
4.1.47. 1-(4-Chlorophenyl)-5-phenylpent-1-yn-3-one
This compound is novel. This compound was prepared using
General Procedure 3 from compound 34 (0.285 g, 1.42 mmol, 1 eq.)
and MnO2 (0.855 g, 9.95 mmol, 7 eq.) to yield the desired product as
a yellow solid (0.246 g, 0.91 mmol, 64%). dH (300 MHz, CDCl3)
7.52e7.44 (2H, m, ArH), 7.38e7.21 (7H, m, ArH), 3.09e2.96 (4H, m,
CH2CH2Ph); dC (75 MHz, CDCl3) 162.3, 161.6, 140.5, 134.6, 129.1,
4.1.44. (E)-5-(4-Chlorophenyl)-1-phenylpent-1-en-4-yn-3-one
This compound is known and fully characterised [53]. 1-Chloro-
4-ethynylbenzene was prepared as reported [52]. This compound
128.6, 128.4, 126.4, 116.9, 89.6, 88.5, 46.9, 29.9; HRMS (ESI) m/z:
35
[MþNa]þ calcd for C17
H ClNaO 291.0547, found 291.0552; IR (v):
13
13